CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tonghua Dongbao Medicines Company Limited Company Snapshot
Tonghua Dongbao Medicines Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tonghua Dongbao Medicines Company Limited with three other companies in this sector in China: Hualan Biological Engineering Inc (2016 sales of 1.93 billion Chinese Renmimbi [US$295.35 million] of which 94% was Blood Product), China Biologic Products Holdings Inc (2.27 billion Chinese Renmimbi [US$346.62 million] of which 100% was Human Blood Product), and Beijing Tiantan Biologic. (2.10 billion Chinese Renmimbi [US$319.97 million] of which 99% was Biological products industry).

Sales Analysis. Tonghua Dongbao Medicines Company Limited reported sales of 2.03 billion Chinese Renmimbi (US$309.97 million) for the year ending December of 2016. This represents an increase of 21.7% versus 2015, when the company's sales were 1.67 billion Chinese Renmimbi. Sales at Tonghua Dongbao Medicines Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 159%). Sales of Pharmaceutical saw an increase of 19.8% in 2016, from 1.62 billion Chinese Renmimbi to 1.95 billion Chinese Renmimbi. Not all segments of Tonghua Dongbao Medicines Company Limited experienced an increase in sales in 2016: sales of Plastic Construction Material fell 43.0% to 26.09 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tonghua Dongbao Medicines Company Limited
  Stock Performance Chart for Tonghua Dongbao Medicines Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 19.22
(Figures in Chinese Renmimbi)
1 Week 0.1%   13 Weeks 6.0%  
4 Weeks 11.7%   52 Weeks 5.1%  
 
Tonghua Dongbao Medicines Company Limited Key Data:
  Ticker: 600867 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 2,029,908,565
(Year Ending Jan 2017).
Employees: 2,094
  Currency: Chinese Renmimbi Market Cap: 32,795,473,802
  Fiscal Yr Ends: December Shares Outstanding: 1,706,320,177
  Share Type: A Gu Closely Held Shares: 789,848,180
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.